Pembro Provides DFS Benefit in Early NSCLC
Adjuvant pembrolizumab significantly improved disease-free survival (DFS) compared to placebo in patients who had undergone complete resection, according to findings from the phase 3 PEARLS study.
Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adjuvant pembrolizumab significantly improved disease-free survival (DFS) compared to placebo in patients who had undergone complete resection, according to findings from the phase 3 PEARLS study.
Is thejudge found might file against them. bottom line is the judge found that it was ambiguous in terms of the resection of the settlement. and that prince andrew who is not specifically named as someone who was to be released from any additional claims or claims prior to that date of settlement that he is not covered by that release. so that means that the lawsuit by virginia against prince andrew can continue. that also means thejudge was saying andrew can continue. that also means the judge was saying he's not drawing any conclusions as to whether or not what virginia alleges against princ...
Neuroendoscopic treatment of brain abscess is associated with definite curative effects and rapid postoperative recovery.
The new findings may provide some reassurance to oncologists about patients' preference for surgery. The study was published as a preprint and has not yet been peer reviewed.
A downside to treating appendicitis with antibiotics is that appendiceal cancer can be missed.